Trial
NCT00014131
Vaccine Therapy in Treating Patients With Kidney Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Lisata Therapeutics, Inc.
Collaborators
—
Condition
Kidney Cancer
Intervention
Biological/Vaccine: therapeutic autologous dendritic cells.
Why stopped
change in corporate priorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-04